Ago Mrsa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ago Mrsa has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandra Aizenshtadt
Hybrid Technology Hub, Institute of Basic Medical Science, University of Oslo, P.O. Box 1110, 0317 Oslo, Norway
1 shared publication - Elsa Lundanes
University of Oslo
1 shared publication - Frederik Hansen
University of Oslo
1 shared publication - Frøydis Sved Skottvoll
University of Oslo
1 shared publication - Gareth John Sullivan
University of Oslo
1 shared publication - Ida Caroline Sneis Boger
University of Oslo
1 shared publication
Latest Publications
- Open Access
Electromembrane extraction and mass spectrometry for liver organoid drug metabolism studies
Liver organoids are emerging tools for precision drug development and toxicity screening. We demonstrate that electromembrane extraction (EME) based on electrophoresis across an oil membrane is suited for segregating selected organoid-derived drug metabolites prior to mass spectrometry (MS)-based measurements. EME, allowed drugs and drug metabolites to be separated from cell medium components (albumin, etc.) that could interfere with subsequent measurements. Multi-well EME (Parallel-EME) holding 100 μL solutions allowed for simple and repeatable monitoring of heroin phase I metabolism kinetics. Organoid Parallel-EME extracts were compatible with ultrahigh-performance liquid chromatography (UHPLC) used to separate the analytes prior to detection. Taken together, liver organoids are well-matched with EME followed by MS-based measurements.
Open AccessElectromembrane extraction and mass spectrometry for liver organoid drug metabolism studies
Liver organoids are emerging tools for precision drug development and toxicity screening. We demonstrate that electromembrane extraction (EME) based on electrophoresis across an oil membrane is suited for segregating selected organoid-derived drug metabolites prior to mass spectrometry (MS)-based measurements. EME, allowed drugs and drug metabolites to be separated from cell medium components (albumin, etc.) that could interfere with subsequent measurements. Multi-well EME (Parallel-EME) holding 100 μL solutions allowed for simple and repeatable monitoring of heroin phase I metabolism kinetics. Organoid Parallel-EME extracts were compatible with ultrahigh-performance liquid chromatography (UHPLC) used to separate the analytes prior to detection. Taken together, liver organoids are well-matched with EME followed by MS-based measurements.